These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25987470)

  • 1. Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma.
    Belletti D; Tosi G; Riva G; Lagreca I; Galliania M; Luppi M; Vandelli MA; Forni F; Ruozi B
    Int J Pharm; 2015 Jul; 490(1-2):85-93. PubMed ID: 25987470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted nutlin-3a loaded nanoparticles inhibiting p53-MDM2 interaction: novel strategy for breast cancer therapy.
    Das M; Dilnawaz F; Sahoo SK
    Nanomedicine (Lond); 2011 Apr; 6(3):489-507. PubMed ID: 21542687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach.
    Belletti D; Riva G; Luppi M; Tosi G; Forni F; Vandelli MA; Ruozi B; Pederzoli F
    Eur J Pharm Sci; 2017 Sep; 107():230-239. PubMed ID: 28728978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
    Yang A; Liu Z; Yan B; Zhou M; Xiong X
    Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy.
    Das M; Sahoo SK
    Acta Biomater; 2011 Jan; 7(1):355-69. PubMed ID: 20727991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
    Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
    J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma.
    Tomasina J; Poulain L; Abeilard E; Giffard F; Brotin E; Carduner L; Carreiras F; Gauduchon P; Rault S; Malzert-Fréon A
    Int J Pharm; 2013 Dec; 458(1):197-207. PubMed ID: 24084450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells.
    Cirstoiu-Hapca A; Buchegger F; Bossy L; Kosinski M; Gurny R; Delie F
    Eur J Pharm Sci; 2009 Oct; 38(3):230-7. PubMed ID: 19632322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
    Jiang S; Gong X; Zhao X; Zu Y
    Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin loaded poly(2-hydroxyethyl methacrylate) nanoparticles from gelled ionic liquid--in vitro cytotoxicity and anti-cancer activity in SKOV-3 cells.
    Kumar SS; Surianarayanan M; Vijayaraghavan R; Mandal AB; MacFarlane DR
    Eur J Pharm Sci; 2014 Jan; 51():34-44. PubMed ID: 24012589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
    Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
    Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization and in vitro-targeted delivery of novel Apolipoprotein E-based nanoparticles to C6 glioma with controlled size and loading efficiency.
    Maleklou N; Allameh A; Kazemi B
    J Drug Target; 2016; 24(4):348-58. PubMed ID: 26302967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly nanoparticles for the delivery of bisphosphonates into tumors.
    Salzano G; Marra M; Porru M; Zappavigna S; Abbruzzese A; La Rotonda MI; Leonetti C; Caraglia M; De Rosa G
    Int J Pharm; 2011 Jan; 403(1-2):292-7. PubMed ID: 21055454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
    Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
    Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.